PRESS RELEASE published on 01/17/2024 at 12:00, 1 year 2 months ago UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review UTILITY therapeutics Ltd. announces a private financing led by the AMR Action Fund and the U.S. FDA's acceptance of its New Drug Application (NDA) for PIVYA, a European-approved antibiotic for the treatment of uncomplicated urinary tract infections (UTIs). PIVYA has received the FDA's qualified infectious disease product (QIDP) designation, providing an additional 5 years of market exclusivity upon approval. This new antibiotic offers a unique mechanism of action and aims to address the rising rates of antimicrobial resistance. For more information, visit www.utilitytherapeutics.com. UTILITY Therapeutics PIVYA Urinary Tract Infections Antibiotic FDA Approval
Published on 04/02/2025 at 23:35, 23 minutes ago Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 3 hours 58 minutes ago Network-1 Announces Acquisition of Patent Portfolio
Published on 04/02/2025 at 15:00, 8 hours 58 minutes ago Doubleview Gold Corp 2025 Exploration Program
Published on 04/02/2025 at 14:00, 9 hours 58 minutes ago Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Published on 04/02/2025 at 20:20, 3 hours 37 minutes ago EQS-Adhoc: Siemens Aktiengesellschaft: Siemens acquires Dotmatics to extend AI-powered software portfolio to Life Sciences
Published on 04/02/2025 at 20:01, 3 hours 57 minutes ago Annual General Meeting of Deutsche Konsum REIT-AG successfully held
Published on 04/02/2025 at 20:01, 3 hours 57 minutes ago Travis Perkins: Publication of the Annual Report and Accounts 2024
Published on 04/02/2025 at 19:40, 4 hours 17 minutes ago LION E-Mobility AG starts successfully into the new 2025 financial year – Challenging market environment impacts 2024
Published on 04/02/2025 at 19:13, 4 hours 45 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/02/2025 at 17:45, 6 hours 13 minutes ago Aéroports de Paris SA - Voting rights as of 31 March 2025
Published on 04/02/2025 at 17:45, 6 hours 13 minutes ago Availability of the Pre-Q1 2025 Sales Communication
Published on 04/02/2025 at 17:45, 6 hours 13 minutes ago Information concerning the total number of voting rights and shares 2025 03 31
Published on 04/01/2025 at 17:45, 1 day 6 hours ago Covivio - Information on total number of voting rights and share capital